TOCANCIPÁ, Colombia, April 26, 2024 (GLOBE NEWSWIRE) -- Clever Leaves Holdings Inc. (NASDAQ: CLVR, CLVRW) (“Clever Leaves” or the “Company”), a global medicinal cannabis company, today announced that its Board of Directors (the “Board”) determined to voluntarily delist its common shares, without par value (the “common shares”) and warrants, each exercisable for 1/30th common share at an exercise price of $11.50 (the... Read More

TOCANCIPÁ, Colombia, April 01, 2024 (GLOBE NEWSWIRE) -- Clever Leaves Holdings Inc. (NASDAQ: CLVR, CLVRW) (“Clever Leaves” or the “Company”), a global medicinal cannabis company, is reporting financial and operating results for the fourth quarter and full year ended December 31, 2023. All financial information is provided in US dollars unless otherwise indicated. “Throughout 2023, we executed on our strategic initiatives to... Read More

TOCANCIPÁ, Colombia, Feb. 13, 2024 (GLOBE NEWSWIRE) -- Clever Leaves Holdings Inc. (NASDAQ: CLVR, CLVRW) (“Clever Leaves” or the “Company”), a global medicinal cannabis company, announced today that through its partnership with award-winning Dutch seed bank, Paradise Seeds (“Paradise”), to develop and register high performance cannabis cultivars in Colombia, Clever Leaves will have exclusive license to cultivate some of... Read More

Multinational operator has been granted Australian GMP certification by the TGA for the manufacturing of cannabis products. Clever Leaves is the first and only medicinal cannabis company globally that has GMP certifications from the European Union, Colombia, Brazil and Australia. TOCANCIPÁ, Colombia, Jan. 03, 2024 (GLOBE NEWSWIRE) -- Clever Leaves Holdings Inc. (NASDAQ: CLVR, CLVRW), a global medicinal cannabis company,... Read More

TOCANCIPÁ, Colombia, Nov. 09, 2023 (GLOBE NEWSWIRE) -- Clever Leaves Holdings Inc. (NASDAQ: CLVR, CLVRW) (“Clever Leaves” or the “Company”), a global medicinal cannabis company, is reporting financial and operating results for the third quarter ended September 30, 2023. All financial information is provided in US dollars unless otherwise indicated. “Our third quarter results reflect our commitment to enhancing our commercial... Read More

TOCANCIPÁ, Colombia, Nov. 02, 2023 (GLOBE NEWSWIRE) -- Clever Leaves Holdings Inc. (NASDAQ: CLVR, CLVRW) (“Clever Leaves” or the “Company”), a global medicinal cannabis company, will hold a conference call on Thursday, November 9, 2023 at 5:00 p.m. Eastern time to discuss its results for the third quarter ended September 30, 2023. The Company will provide its financial results in a press release prior to the conference call.... Read More

TOCANCIPÁ, Colombia, Sept. 13, 2023 (GLOBE NEWSWIRE) -- Clever Leaves Holdings Inc. (NASDAQ: CLVR, CLVRW) (“Clever Leaves” or the “Company”), a global medicinal cannabis company, announced that it received notice from The Nasdaq Stock Market LLC ("Nasdaq") on September 11, 2023 informing the Company that it has regained compliance with the minimum bid price requirement under Nasdaq Listing Rule 5550(a)(2) (the "Rule") for... Read More

The CO2 Neutrality Certification Reflects Clever Leaves’ Commitment to Environmental Sustainability and long-term vision for the cannabis industry. Sustainable cannabis production has a significant impact on the environment: Clever Leaves generates just 16 kilograms of CO2 compared to traditional "indoor" cultivation methods that generate up to 2,300 to 5,200 kilograms of CO2 per kilogram of dried flower. TOCANCIPÁ,... Read More

TOCANCIPÁ, Colombia, Aug. 24, 2023 (GLOBE NEWSWIRE) -- Clever Leaves Holdings Inc. (NASDAQ: CLVR, CLVRW) (“Clever Leaves” or the “Company”), a global medicinal cannabis company, announced that its Board of Directors has approved a 1-for-30 reverse split of its common shares (the “Reverse Share Split”). The Reverse Share Split will take effect at approximately 5:00 p.m. Eastern Time on August 24, 2023. As a result of the... Read More

Total Revenue Increased 21% Year-Over-Year, Driven by 151% Year-Over-Year Growth in Cannabinoid Revenue Continued Expense Reductions Drive Improved Adjusted EBITDA Performance of ($2.1) Million July 2023 Sale of Portuguese Processing Assets Added $2.7 Million in Cash Following the End of Q2 Reaffirming Previously Announced 2023 Guidance TOCANCIPÁ, Colombia, Aug. 14, 2023 (GLOBE NEWSWIRE) -- Clever Leaves Holdings Inc.... Read More

TOCANCIPÁ, Colombia, Aug. 07, 2023 (GLOBE NEWSWIRE) -- Clever Leaves Holdings Inc. (NASDAQ: CLVR, CLVRW) (“Clever Leaves” or the “Company”), a global medicinal cannabis company, will hold a conference call on Monday, August 14, 2023 at 5:00 p.m. Eastern time to discuss its results for the second quarter ended June 30, 2023. The Company will provide its financial results in a press release prior to the conference call. Clever... Read More

TOCANCIPÁ, Colombia and SYDNEY, Australia, July 26, 2023 (GLOBE NEWSWIRE) -- Clever Leaves Holdings Inc. (NASDAQ: CLVR, CLVRW) (“Clever Leaves” or the “Company”), a global medicinal cannabis company, announced that its Colombian flower is now available to patients in Australia through a partnership with Australian Natural Therapeutics Group (“ANTG”), one of the leading medicinal cannabis providers in Australia. The products... Read More

TOCANCIPÁ, Colombia, July 05, 2023 (GLOBE NEWSWIRE) -- Clever Leaves Holdings Inc. (NASDAQ: CLVR, CLVRW) (“Clever Leaves” or the “Company”), a global medicinal cannabis company, announced it has closed the sale of the assets, including lab and processing equipment, previously used in its EU-GMP certified cannabis processing facility in Setúbal, Portugal, as controlled by its wholly owned subsidiary, Clever Leaves Portugal... Read More

TOCANCIPÁ, Colombia, May 30, 2023 (GLOBE NEWSWIRE) -- Clever Leaves Holdings Inc. (NASDAQ: CLVR, CLVRW) (“Clever Leaves”), a global medicinal cannabis company, announced today the arrival of the company’s first shipment of medical cannabis extracts from Colombia to Switzerland-based partner, Astrasana Holding AG (“Astrasana”). This marks the first commercial shipment for Clever Leaves to Switzerland, where Astrasana is an... Read More

TOCANCIPÁ, Colombia, May 26, 2023 (GLOBE NEWSWIRE) -- Clever Leaves Holdings Inc. (NASDAQ: CLVR, CLVRW) (“Clever Leaves” or the “Company”), a global medicinal cannabis company, reminds shareholders that it will hold its 2023 Annual Meeting of Shareholders (the “Annual Meeting”) on Friday, June 2, 2023 at 10:00 a.m. Eastern Time. The Annual Meeting will be in a virtual-only format. Clever Leaves reminds investors that its... Read More

TOCANCIPÁ, Colombia, May 25, 2023 (GLOBE NEWSWIRE) -- Clever Leaves Holdings Inc. (NASDAQ: CLVR, CLVRW), a global medicinal cannabis company, announced today that it has entered into a five-year agreement with SOMAÍ Pharmaceuticals, to supply its operations in Portugal with EU-GMP certified CBD extracts from Colombia. With the first shipments under the agreement already completed, Clever Leaves will continue to supply EU-GMP... Read More

Multinational operator has been granted Brazilian GMP certification by ANVISA for the manufacturing of cannabis products Clever Leaves is the first and only medicinal cannabis company globally who has GMP certifications from the EU, Colombia and Brazil TOCANCIPÁ, Colombia, May 16, 2023 (GLOBE NEWSWIRE) -- Clever Leaves Holdings Inc. (NASDAQ: CLVR, CLVRW), a global medicinal cannabis company, announced today that the Company... Read More

TOCANCIPÁ, Colombia, May 15, 2023 (GLOBE NEWSWIRE) -- Clever Leaves Holdings Inc. (NASDAQ: CLVR, CLVRW) (“Clever Leaves” or the “Company”), a global medicinal cannabis company, is scheduled to participate in Canaccord Genuity’s 7 th Annual Global Cannabis Conference, which is being held on May 18, 2023 at the Westin NY Grand Central in New York, NY. Clever Leaves management is scheduled to present on Thursday, May 18 th at... Read More

Continued Commercial Momentum Within Core Cannabinoid Markets Recent Commercial Launches of Colombian Dry Flower Exports to Australia and Germany Mark Key Operational Milestone Continuing Cost Reduction Measures Drive Leaner Operational Infrastructure Reiterating Previously Issued 2023 Outlook TOCANCIPÁ, Colombia, May 11, 2023 (GLOBE NEWSWIRE) -- Clever Leaves Holdings Inc. (NASDAQ: CLVR, CLVRW) (“Clever Leaves” or the... Read More

TOCANCIPÁ, Colombia, May 04, 2023 (GLOBE NEWSWIRE) -- Clever Leaves Holdings Inc. (NASDAQ: CLVR, CLVRW) (“Clever Leaves” or the “Company”), a leading multinational operator and licensed producer of pharmaceutical-grade cannabinoids, will hold a conference call on Thursday, May 11, 2023 at 5:00 p.m. Eastern time to discuss its results for the first quarter ended March 31, 2023. The Company will provide its financial results... Read More

TOCANCIPÁ, Colombia, April 18, 2023 (GLOBE NEWSWIRE) -- Clever Leaves Holdings Inc. (NASDAQ: CLVR, CLVRW), a global medicinal cannabis company, announced today that it has entered into a five-year agreement with Hypera Pharma (B3: HYPE3), a leading pharmaceutical company in Brazil, to supply Clever Leaves’ CBD-dominant oral solutions with the aim of treating various medical conditions and prescribing to Brazilian patients.... Read More

TOCANCIPÁ, Colombia, April 11, 2023 (GLOBE NEWSWIRE) -- Clever Leaves Holdings Inc. (NASDAQ: CLVR, CLVRW) (“Clever Leaves” or the “Company”), a global medical cannabis company, announced today its commercial agreement with US-based Praetorian Global Inc. (“Praetorian”), a leading brand owner and intellectual property provider to the global cannabis and hemp industry, to produce premium quality cannabis flower and downstream... Read More

TOCANCIPÁ, Colombia, April 03, 2023 (GLOBE NEWSWIRE) -- Clever Leaves Holdings Inc. (NASDAQ: CLVR, CLVRW) (“Clever Leaves” or the “Company”), a leading multinational operator and licensed producer of pharmaceutical-grade cannabinoids, announced today that it will be presenting virtually at the upcoming Sequire Cannabis & Psychedelics Conference on Wednesday, April 5, at 2:30 p.m. Eastern time. Event: Clever Leaves... Read More

Fourth Quarter and Full Year 2022 Cannabinoid Revenue Increased 71% and 90%, Respectively; Total Annual Revenue Growth was 16% Year-over-Year Steady Cost Reductions and Portugal Wind-Down Expected to Drive Production, Cost, and CapEx Efficiencies Announces Financial Outlook and Key Focus Markets for 2023 TOCANCIPÁ, Colombia, March 30, 2023 (GLOBE NEWSWIRE) -- Clever Leaves Holdings Inc. (NASDAQ: CLVR, CLVRW) (“Clever Leaves”... Read More

TOCANCIPÁ, Colombia, March 17, 2023 (GLOBE NEWSWIRE) -- Clever Leaves Holdings Inc. (NASDAQ: CLVR, CLVRW) (“Clever Leaves” or the “Company”), a leading multinational operator and licensed producer of pharmaceutical-grade cannabinoids, announced that it will be rescheduling its previously planned conference call on Thursday, March 23, 2023 at 5:00 p.m. ET to discuss its financial results for the fourth quarter and full year... Read More

TOCANCIPÁ, Colombia, March 09, 2023 (GLOBE NEWSWIRE) -- Clever Leaves Holdings Inc. (NASDAQ: CLVR, CLVRW) (“Clever Leaves” or the “Company”), a leading multinational operator and licensed producer of pharmaceutical-grade cannabinoids, will hold a conference call on Thursday, March 23, 2023 at 5:00 p.m. Eastern time to discuss its results for the fourth quarter and full year ended December 31, 2022. The Company will provide... Read More

Company to Concentrate All Cannabinoid Cultivation and Production Operations in Colombia to Leverage Existing Operational Efficiencies Operational Transition Expected to Generate Approximately $7 Million in Cost Savings by Year-End 2023 TOCANCIPÁ, Colombia, Jan. 23, 2023 (GLOBE NEWSWIRE) -- Clever Leaves Holdings Inc. (Nasdaq: CLVR, CLVRW) (“Clever Leaves” or the “Company”), a leading multinational operator and licensed... Read More

Q3 Cannabinoid Revenue Increases 12% Year-Over-Year, with 100% Growth in the Segment Year-to-Date Significant Continued Progress on Cost Reduction Initiatives Driving Sequential Improvements in Adjusted EBITDA Continued Financial Discipline, Operational Improvements, Commercial Traction and Regulatory Shifts Strengthen Foundation for Long-Term Growth and Profitability TOCANCIPÁ, Colombia, Nov. 09, 2022 (GLOBE NEWSWIRE) --... Read More

TOCANCIPÁ, Colombia, Nov. 09, 2022 (GLOBE NEWSWIRE) -- Clever Leaves Holdings Inc. (NASDAQ: CLVR, CLVRW), a leading multinational operator and licensed producer of pharmaceutical-grade cannabinoids, announced today that its facility in Portugal has been granted EU-GMP certification by the Portuguese Health Authority (INFARMED, I.P.) to manufacture dried cannabis flower as an active pharmaceutical ingredient and as finished... Read More

Peruvian operator Anden Naturals has obtained sanitary registration from the Peruvian Health Authority for its THC dominant products Clever Leaves will cultivate, manufacture, and pack Anden Naturals’ finished products in its EUGMP certified facilities in Colombia Clever Leaves Holdings Inc. (NASDAQ: CLVR, CLVRW), a leading multinational operator and licensed producer of pharmaceutical-grade cannabinoids, announced today... Read More

Clever Leaves Holdings Inc. (NASDAQ: CLVR, CLVRW) (“Clever Leaves” or the “Company”), a leading multinational operator and licensed producer of pharmaceutical-grade cannabinoids, will hold a conference call on Wednesday, November 9, 2022 at 5:00 p.m. Eastern time to discuss its results for the third quarter ended September 30, 2022. The Company will provide its financial results in a press release prior to the conference... Read More

Clever Leaves Holdings Inc. (NASDAQ: CLVR, CLVRW), a leading multinational operator and licensed producer of pharmaceutical-grade cannabinoids, announced a partnership today with U.S. cannabis-branded genetic innovation company, House of Kush, to be the exclusive grower and distributor of proprietary genetics globally. Clever Leaves will be the exclusive producer of various genetics for House of Kush outside of the United... Read More

Revenue Increased 27% Year-Over-Year to $4.7 Million, Reflecting Continued Commercial Momentum in Target Markets Significant Debt Reduction and Restructuring Initiatives Create Enhanced Capital Efficiency Reiterating 2022 Financial Guidance Clever Leaves Holdings Inc. (Nasdaq: CLVR, CLVRW) (“Clever Leaves” or the “Company”), a leading multinational operator and licensed producer of pharmaceutical-grade cannabinoids, is... Read More

Clever Leaves Holdings Inc. (NASDAQ: CLVR, CLVRW) (“Clever Leaves” or the “Company”), a leading multinational operator and licensed producer of pharmaceutical-grade cannabinoids, will hold a conference call on Thursday, August 11, 2022 at 5:00 p.m. Eastern time to discuss its results for the second quarter ended June 30, 2022. The Company will provide its financial results in a press release prior to the conference call.... Read More

Clever Leaves Holdings Inc. (NASDAQ: CLVR, CLVRW) (“Clever Leaves” or the “Company”), a leading multinational operator and licensed producer of pharmaceutical-grade cannabinoids, announced today the first commercial export to Israel of high THC Flower for medical use from its facility in Portugal through its partnership with InterCure (Nasdaq: INCR, TSX: INCR.U, TASE: INCR). With this initial shipment, medical cannabis... Read More

Clever Leaves Holdings Inc. (NASDAQ: CLVR, CLVRW) (“Clever Leaves” or the “Company”), a multinational operator and licensed producer of pharmaceutical-grade cannabinoids, announced today the continued expansion of the Company’s partnership with European medical cannabis leader Cantourage GmbH (“Cantourage”) to include supply of Clever Leaves’ second pharmaceutical-grade cannabis product, cultivated in the Company’s Portugal... Read More

Cantourage introduces second Clever Leaves medical cannabis product to the German market IQANNA No 10, a high-THC dried flower product based on the Wappa cultivar, produced at Clever Leaves' Portugal facility, is available in German pharmacies Caroline Kliess, Managing Director of Clever Leaves Germany, comments: "We are excited to intensify our partnership with Cantourage and launch our next medical cannabis flower product... Read More

Revenue Increased 50% Year-Over-Year to $5.2 Million Commercial Progress Across Target Markets Demonstrates Strong Execution on Redefined Growth Strategy Additional Proactive Steps Taken to Enhance the Company’s Cost Structure Significant Debt Pay-Down Achieved Subsequent to Quarter End Reiterating Previously Provided 2022 Outlook Clever Leaves Holdings Inc. (Nasdaq: CLVR, CLVRW) (“Clever Leaves” or the “Company”), a leading... Read More

Clever Leaves Holdings Inc. (NASDAQ: CLVR, CLVRW) (“Clever Leaves” or the “Company”), a leading multinational operator and licensed producer of pharmaceutical-grade cannabinoids, is scheduled to participate in the following investor conferences in May 2022: Canaccord Genuity 6 th Annual Cannabis Conference Format: Virtual Presentation Date and Time: Wednesday, May 11 th at 8:00 a.m. Eastern time Webcast:... Read More

Clever Leaves Holdings Inc. (NASDAQ: CLVR, CLVRW) (“Clever Leaves” or the “Company”), a leading multinational operator and licensed producer of pharmaceutical-grade cannabinoids, will hold a conference call on Thursday, May 12, 2022 at 5:00 p.m. Eastern time to discuss its results for the first quarter ended March 31, 2022. The Company will provide its financial results in a press release prior to the conference call. Clever... Read More

Clever Leaves Holdings Inc. (NASDAQ: CLVR, CLVRW) (“Clever Leaves” or the “Company”), a leading multinational operator and licensed producer of pharmaceutical-grade cannabinoids, announced today that its affiliate in Germany, Clever Leaves Germany GmbH, has received all of the required regulatory licenses, permits and certifications by the German authorities to be able to distribute medical cannabis to wholesalers and around... Read More

Clever Leaves Holdings Inc. (NASDAQ: CLVR, CLVRW) (“Clever Leaves” or the “Company”), a leading multinational operator and licensed producer of pharmaceutical-grade cannabinoids today announced a two-year supply agreement with American, clinical-stage biopharmaceutical company, Biom Therapeutics (“Biom”) to provide high quality CBD isolate. Clever Leaves has already provided Biom Therapeutics with the first shipment of EU... Read More

Clever Leaves Holdings Inc. (NASDAQ: CLVR, CLVRW) (“Clever Leaves” or the “Company”), a leading multinational operator and licensed producer of pharmaceutical-grade cannabinoids, is scheduled to participate in the following investor conferences in April 2022: BTIG Global Cannabis Conference Fireside Chat: Thursday, April 7 th at 10:30 a.m. ET Sequire Cannabis & Psychedelic Conference Presentation: Wednesday, April 20 th at... Read More

Clever Leaves celebrates the issuance of Joint Resolution 539 of 2022 that marks the completion of the regulatory framework for the export of medical cannabis flowers from Colombia. To take advantage of the regulatory change, the Company has already been working on developing the product to meet market needs and on setting the regulatory and logistics pathways for exports. Clever Leaves has signed commercial agreements to... Read More

Fourth Quarter and Full Year Revenue Increased 25% and 27%, Respectively - Ongoing Commercial Progress in Core Markets and Refined Strategic Focus Provide Strong Foundation for Growth in 2022 - Reiterating Previously Provided 2022 Guidance - Clever Leaves Holdings Inc. (Nasdaq: CLVR, CLVRW) (“Clever Leaves” or the “Company”), a leading multinational operator and licensed producer of pharmaceutical-grade cannabinoids, is... Read More

InterCure Ltd . (NASDAQ: INCR) (TSX: INCR.U) (TASE: INCR) (dba Canndoc)("InterCure" or the “Company”) and Clever Leaves Holdings Inc. (NASDAQ: CLVR, CLVRW) (“Clever Leaves”), a leading multinational operator and licensed producer of pharmaceutical-grade cannabinoids, today announced the execution of an exclusive multi-year cultivation, marketing and distribution agreement (the "Agreement"). Over the term of the Agreement,... Read More

Clever Leaves Holdings Inc. (NASDAQ: CLVR, CLVRW) (“Clever Leaves” or the “Company”), a leading multinational operator and licensed producer of pharmaceutical-grade cannabinoids, announced that it has appointed William Muecke to its board of directors, effective March 25, 2022, to fill the vacancy resulting from the previously announced departure of Kyle Detwiler, the Company’s current chairman and CEO, effective March 24,... Read More

Clever Leaves Holdings Inc. (NASDAQ: CLVR, CLVRW) (“Clever Leaves” or the “Company”), a leading multinational operator and licensed producer of pharmaceutical-grade cannabinoids, will hold a conference call on Thursday, March 24, 2022 at 5:00 p.m. Eastern time to discuss its results for the fourth quarter and full year ended December 31, 2021. The Company will provide its financial results in a press release prior to the... Read More

Clever Leaves Holdings Inc. (NASDAQ: CLVR, CLVRW) (“Clever Leaves” or the “Company”), a leading multinational operator and licensed producer of pharmaceutical-grade cannabinoids, is scheduled to participate in the 34 th Annual ROTH Conference, which is being held on March 13-15, 2022 at the Ritz Carlton in Dana Point, CA. Clever Leaves management is scheduled to present on Tuesday, March 15 th at 2:00 p.m. Pacific time. The... Read More

A supply agreement between cannabis operators Clever Leaves and FoliuMed allows for the exportation of pharmaceutical grade cannabis bulk extracts from Colombia to Germany. Clever Leaves Holdings Inc. (NASDAQ: CLVR, CLVRW) (“Clever Leaves” or the “Company”), a leading multinational operator and licensed producer of pharmaceutical-grade cannabinoids, has signed a one-year international sales agreement with German- Colombian... Read More

Clever Leaves Holdings Inc. (NASDAQ: CLVR, CLVRW) (“Clever Leaves” or the “Company”), a leading multinational operator and licensed producer of pharmaceutical-grade cannabinoids, today announced the expansion of its partnership with German cannabis distributor and wholesaler Cansativa GmbH (“Cansativa”). At the same time, Cansativa announced a Series B fundraise, enhancing Cansativa’s ability to grow, capitalize on the... Read More

Clever Leaves Holdings Inc. (NASDAQ: CLVR, CLVRW) (“Clever Leaves Holdings” or the “Company”), a leading multinational operator and licensed producer of pharmaceutical-grade cannabinoids, today announced the importation of its first German high-quality standards compliant commercial extracts that will soon be available for distribution by its partner in Germany Ethypharm GmbH (“Ethypharm”), a European specialty... Read More

Clever Leaves Holdings Inc. (NASDAQ: CLVR, CLVRW) (“Clever Leaves” or the “Company”), a leading multinational operator and licensed producer of pharmaceutical-grade cannabinoids today announced an expansion of its relationship with Australian medical cannabis company Cannatrek Ltd. (“Cannatrek”) by signing a two-year, take-or-pay basis supply agreement that includes high-THC flower from Portugal, while expanding on its... Read More

Performance Delivers on 2021 Outlook and Provides Solid Foundation for 2022 2022 Outlook and Strategic Growth Objectives Reflect Ramping Commercialization Opportunities Within Core Global Markets Clever Leaves Holdings Inc. (NASDAQ: CLVR, CLVRW) (“Clever Leaves” or the “Company”), a leading multinational operator and licensed producer of pharmaceutical-grade cannabinoids, today announced its preliminary unaudited financial... Read More

Clever Leaves Holdings Inc. (NASDAQ: CLVR, CLVRW) (“Clever Leaves” or the “Company”), a leading multinational operator and licensed producer of pharmaceutical-grade cannabinoids, today announced a leadership transition plan. Andres Fajardo, currently a director and president of the Company, has been selected to succeed Kyle Detwiler as CEO, effective March 24, 2022. Detwiler will remain CEO until March 24, 2022, to ensure a... Read More

Clever Leaves Holdings Inc . (NASDAQ: CLVR, CLVRW) (“Clever Leaves” or the “Company”), a leading multinational operator and licensed producer of pharmaceutical-grade cannabinoids, today announced its entrance to the U.S. CBD market through the launch of its consumer-oriented CBD line JoySol™. JoySol is produced by... Read More

Clever Leaves Holdings Inc. (NASDAQ: CLVR, CLVRW) (“Clever Leaves” or the “Company”), a leading multinational operator and licensed producer of pharmaceutical-grade cannabinoids, is scheduled to participate in the 2022 ICR Conference, which is being held virtually from January 10-12, 2022. Clever Leaves management is scheduled to present on Monday, January 10 th at 8:30am ET. The presentation will be webcast live and... Read More

Clever Leaves Holdings Inc. (NASDAQ: CLVR, CLVRW) (“Clever Leaves” or the “Company”), a leading multinational operator and licensed producer of pharmaceutical-grade cannabinoids, today announces the official licensing of its expanded greenhouse facilities by the Portuguese regulatory health authority, INFARMED, I.P. With the preexisting facilities licensed in August 2020, this new milestone extends the licensed cultivation... Read More

Clever Leaves Holdings Inc. (NASDAQ: CLVR, CLVRW) (“Clever Leaves” or the “Company”), a leading multinational operator and licensed producer of pharmaceutical-grade cannabinoids, is scheduled to participate in the following investor conferences in November and December 2021: Cowen 4 th Annual Cannabis Conference Date: Monday, November 29 th through Wednesday, December 1 st Where: Virtual panel presentation and 1x1 meetings... Read More

Q3 2021 Revenue Increases to a Record $4.0 Million Gross Profit Increases 22% Year-Over-Year, Gross Margin up 1,000 Basis Points to 62.9% Cultivation Facility Expansion in Portugal Completed Ahead of Schedule and On Budget, Providing Additional Capacity to Support Growing Global Partner Base Clever Leaves Holdings Inc. (Nasdaq: CLVR, CLVRW) (“Clever Leaves” or the “Company”), a leading multinational operator and licensed... Read More

Clever Leaves Holdings Inc. (NASDAQ: CLVR, CLVRW) (“Clever Leaves” or the “Company”), a leading multinational operator and licensed producer of pharmaceutical-grade cannabinoids, will hold a conference call on Wednesday, November 10, 2021 at 5:00 p.m. Eastern time to discuss its results for the third quarter ended September 30, 2021. The Company will provide its financial results in a press release prior to the conference... Read More

Clever Leaves Holdings Inc. (NASDAQ: CLVR, CLVRW) (“Clever Leaves” or the “Company”), a leading multinational operator and licensed producer of pharmaceutical-grade cannabinoids, announced the commercial commencement of a partnership with Pharmalab PHL Laboratories S.A.S (“Pharmalab”) in Colombia. Pharmalab is a Colombian healthcare group specializing in the commercialization and distribution of medicines, dietary... Read More

Clever Leaves Holdings Inc. (NASDAQ: CLVR, CLVRW) (“Clever Leaves” or the “Company”), a leading multinational operator and licensed producer of pharmaceutical-grade cannabinoids, announced today the exportation of 30 kg of high-THC cannabis flower from its Portugal facility to Biopharmaceutical Research Company (“BRC”), a DEA-licensed pharmaceutical company that develops federally compliant active pharmaceutical ingredients... Read More

Clever Leaves Holdings Inc. (Nasdaq: CLVR) (“Clever Leaves” or the “Company”), a leading multinational operator and licensed producer of pharmaceutical-grade cannabinoids, is scheduled to participate in the following investor events in October 2021: A.G.P. Virtual Fall Consumer Cannabis Conference Attending: Tuesday, October 5 th Where: Virtual 1x1 meeting format (no presentations) Lytham Partners Fall 2021 Investor... Read More

Clever Leaves Holdings Inc. (Nasdaq:CLVR) ("Clever Leaves" or the "Company"), a leading multinational operator and licensed producer of pharmaceutical-grade cannabinoids, is scheduled to participate in the following virtual investor conferences in September 2021: 10 th Annual Gateway Conference Presentation: Wednesday, September 8 th at 1:00 p.m. ET Webcast: webcaster4.com/Webcast/Page/2769/42649 KCSA Cannabis Virtual... Read More

- Q2 2021 Revenue Increased 89% and Gross Profit Increased 157% Year-Over-Year - - New Global Partnerships and Launch of U.S. Research Initiative Demonstrate Continued Expansion of Distribution Network - - Reaffirms Previously Stated FY2021 Guidance - NEW YORK, Aug. 12, 2021 (GLOBE NEWSWIRE) -- Clever Leaves Holdings Inc. (Nasdaq: CLVR) (“Clever Leaves” or the “Company”), a leading multinational operator and licensed... Read More

This project will be one of the first sponsored research partnerships under Clever Leaves’ recently announced Project Change Lives Campaign , whereby the Company has pledged to contribute up to US $25 million retail value of medical cannabis products to any eligible U.S. organization in order to help advance scientific research into the medical benefits of cannabinoids. Clever Leaves Holdings Inc. (NASDAQ: CLVR, CLVRW)... Read More

Clever Leaves Holdings Inc. (NASDAQ: CLVR, CLVRW) (“Clever Leaves” or the “Company”), a leading multinational operator and licensed producer of pharmaceutical-grade cannabinoids, will hold a conference call on Thursday, August 12, 2021 at 5:00 p.m. Eastern time to discuss its results for the second quarter ended June 30, 2021. The Company will provide its financial results in a press release prior to the conference call.... Read More

The initiative is part of Project Change Lives; Clever Leaves’ $25M product pledge to aid cannabis research in the U.S. The collaboration represents the Company’s first funded study with a research institution in the United States Clever Leaves Holdings Inc. (NASDAQ: CLVR, CLVRW) (“Clever Leaves” or the “Company”), a leading multinational operator and licensed producer of pharmaceutical-grade cannabinoids, and... Read More

Export of dry cannabis flower from Colombia has been authorized by a new decree that was signed on July 23 rd , 2021, at Clever Leaves’ cultivation facility by President Ivan Duque and his ministers. With flower representing an estimated 50% of global medical cannabis markets, this decree doubles the total addressable market for Clever Leaves’ Colombian operations. 1 Clever Leaves’ Colombian operation is well-positioned to... Read More

Financing Strengthens the Company’s Liquidity Position and Provides Greater Flexibility to Pursue Growth Opportunities Repayment of 2022 Convertible Notes Generates Over $3 Million of Savings Clever Leaves Holdings Inc. (Nasdaq: CLVR) (“Clever Leaves” or the “Company”), a multinational operator and licensed producer of pharmaceutical-grade cannabinoids, today announces the closing of a $25.0 million financing from Catalina... Read More

Medical, clinical and research organizations may apply for consideration in Project Change Lives Initial investigational studies underway in collaboration with Biopharmaceutical Research Company Clever Leaves Holdings Inc. (NASDAQ: CLVR, CLVRW) (“Clever Leaves” or the “Company”), a leading multinational operator and licensed producer of pharmaceutical-grade cannabinoids, announces Project Change Lives, a U.S. focused... Read More

Clever Leaves Holdings Inc. (Nasdaq: CLVR) (“Clever Leaves” or the “Company”), a multinational operator, or MNO, and licensed producer of pharmaceutical-grade cannabinoids, will be presenting at the following investor conferences on Tuesday, June 29, 2021: Cantor Fitzgerald Virtual International Cannabis Forum Presentation Time: 1:00 p.m. Eastern time Webcast: https://zoom.us/webinar/register/WN_gbKfRR3KRuyJ0a2YPh_Alg KCSA... Read More

Clever Leaves Holdings Inc. (NASDAQ: CLVR, CLVRW) (“Clever Leaves” or the “Company”) , a leading multi-national operator and licensed producer of pharmaceutical-grade cannabinoids, today jointly announced a commercial agreement with pharmaceutical manufacturing company, IDT Australia Limited (ASX: IDT, “IDT”), for Clever Leaves to supply to IDT two varieties of bulk GACP 1 certified flower from its facility in Portugal. As... Read More

Clever Leaves Holdings Inc. (NASDAQ: CLVR, CLVRW) (“Clever Leaves” or the “Company”), a leading multinational operator and licensed producer of pharmaceutical-grade cannabinoids, announced it has entered into an active pharmaceutical ingredient (“API”) supply agreement with CBD Life Holding SAPI de CV (“CBD Life”), an emerging leader in the Mexican cannabis industry which offers a line of CBD Wellness and consumer products... Read More

Clever Leaves Holdings Inc. (Nasdaq: CLVR) (“Clever Leaves” or the “Company”), a multinational operator, or MNO, and licensed producer of pharmaceutical-grade cannabinoids, announced that it is set to join the Russell Microcap® Index, effective at market open in the United States on June 28, 2021, upon the conclusion of the Russell indexes’ annual reconstitution. The decision was first disclosed in a preliminary list of... Read More

Clever Leaves Holdings Inc. (Nasdaq: CLVR) (“Clever Leaves” or the “Company”), a multinational operator, or MNO, and licensed producer of pharmaceutical-grade cannabinoids, has been invited to present at the Benzinga Cannabis Capital Conference , which is being held virtually from June 3-4, 2021. Clever Leaves management is scheduled to present on Thursday, June 3 rd at 1:35 p.m. Eastern time, with one-on-one meetings to be... Read More

Q1 2021 Revenue Increased 19% Year-Over-Year Growth in Commercial Partnerships, Certifications, and Successful Initial Shipments Establish a Solid Foundation for Continued Success Reaffirming Previously Stated 2021 Guidance Clever Leaves Holdings Inc. (Nasdaq: CLVR) (“Clever Leaves” or the “Company”), a multinational operator, or MNO, and licensed producer of pharmaceutical-grade cannabinoids, today reported financial and... Read More

Clever Leaves Holdings Inc. (NASDAQ: CLVR, CLVRW) (“Clever Leaves” or the “Company”), a leading multi-national operator, or MNO, and licensed producer of pharmaceutical-grade cannabinoids, will hold a conference call on Monday, May 17, 2021 at 5:00 p.m. Eastern time to discuss its results for the first quarter ended March 31, 2021. The Company will provide its financial results in a press release prior to the conference... Read More

Clever Leaves Holdings Inc. (NASDAQ: CLVR) (“Clever Leaves” or the “Company”) , a leading multi-national operator and licensed producer of pharmaceutical-grade cannabinoids, today announced an agreement with Verdemed Holdings Inc. (“Verdemed”), a Latin American pharmaceutical cannabis company based in Toronto, Canada, to supply finished CBD products for the Brazilian and Peruvian markets. The initial portfolio of products... Read More

Q4 and Full Year 2020 Revenue Increases 28% and 55%, Respectively Continued Growth in Commercial Partnerships and Global Distribution Network Provides Operational Momentum for 2021 Clever Leaves Holdings Inc. (Nasdaq: CLVR) (“Clever Leaves” or the “Company”) today reported financial and operating results for the fourth quarter and full year ended December 31, 2020. All financial information is provided in US dollars unless... Read More

Clever Leaves Holdings Inc. (NASDAQ: CLVR, CLVRW) (“Clever Leaves” or the “Company”), a leading multi-national operator and licensed producer of pharmaceutical-grade cannabinoids, will hold a conference call on Tuesday, March 30, 2021 at 5:00 p.m. Eastern time to discuss its results for the fourth quarter and full year ended December 31, 2020. The Company will provide its financial results in a press release prior to the... Read More

Clever Leaves Holdings Inc. (NASDAQ: CLVR, CLVRW) (“Clever Leaves” or the “Company”) , a leading multi-national operator and licensed producer of pharmaceutical-grade cannabinoids, today announced the signing of a supply agreement with Ethypharm (“Ethypharm”), a European manufacturer and distributor of pharmaceutical products, for the sale of medical cannabis extracts produced in Clever Leaves’ EU-GMP certified facilities in... Read More

Clever Leaves Holdings Inc. (NASDAQ: CLVR, CLVRW) (“Clever Leaves” or the “Company”), a leading multi-national operator and licensed producer of pharmaceutical-grade cannabinoids, today announced that the Colombian Technical Quotas Group ("TQG") authorized Clever Leaves’ Colombian operations to manufacture up to approximately 59,000 kilograms of cannabis into dried flower derivatives. According to the International Narcotics... Read More

Clever Leaves Holdings Inc. (NASDAQ: CLVR, CLVRW) (“Clever Leaves” or the “Company”), a leading multi-national operator and licensed producer of pharmaceutical-grade cannabinoids, announced today the appointment of Hank Hague as its new Chief Financial Officer, effective immediately. Mr. Hague joins Clever Leaves with extensive experience in providing financial leadership to various public and private entities in the... Read More

Clever Leaves Holdings Inc. (NASDAQ: CLVR, CLVRW) (“Clever Leaves” or the “Company”) , a leading multi-national operator and licensed producer of pharmaceutical-grade cannabinoids, announced today it has been added to the Cannabis ETF (NYSE: THCX) ("THCX") , which trades on the New York Stock Exchange. "As one of the few global cannabis operators, inclusion in the Cannabis ETF will allow us to reach a much broader group of... Read More

Clever Leaves Holdings Inc. (NASDAQ: CLVR, CLVRW) (“Clever Leaves” or the “Company”) , a leading multi-national operator and licensed producer of pharmaceutical-grade cannabinoids, announced today its branded nutraceutical manufacturer, Herbal Brands, has entered into a strategic partnership with the LooperGroup and TruSource Hemp Group (“TruSource”), a leading provider of services for the hemp industry, to import the... Read More